Skip to main content
Erschienen in: Pediatric Nephrology 6/2012

01.06.2012

Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria

verfasst von: Augusto C. S. Santos Jr, Eleonora M. Lima, Maria Goretti M. G. Penido, Katia D. Silveira, Mauro M. Teixeira, Eduardo A. Oliveira, Ana Cristina Simões e Silva

Erschienen in: Pediatric Nephrology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Recent studies suggest that cytokines modulate bone turnover. Idiopathic hypercalciuria (IH) seems to be associated with bone mineral loss. Therefore, the aim of this study was to assess cytokines involved in bone turnover in patients with IH.

Methods

Plasma and spot-urine levels of interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor alpha (TNF-α), transforming growth factor β1 (TGF-β1), and monocyte chemoattractant protein (MCP-1) were measured in 70 children and adolescents with IH and in 37 healthy controls. Patients with IH were subdivided according to their calciuria at the time of sample collection: ≥4 mg/kg/day (persistent IH, n=27) and below 4 mg/kg/day (controlled IH, n=43). Cytokines were determined by enzyme-linked immunoassay.

Results

Plasma and urinary concentrations of IL-1β, IL-6, IL-8, and TNF-α were undetectable in all groups. No differences were found between controlled and persistent hypercalciuria for plasma and urinary levels of MCP-1 and TGF-β1. On the other hand, MCP-1 levels were significantly higher in both subgroups of IH in comparison to healthy controls. Furthermore, urinary MCP-1 levels of IH patients correlated positively with bone mineral content (p=0.013).

Conclusion

Although cytokine measurements did not allow the differentiation between persistent and controlled IH, our findings suggest that MCP-1 might play a role in patients with IH.
Literatur
1.
Zurück zum Zitat Albright F, Henneman P, Benedict PH, Forbes AP (1953) Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 46:1077–1081PubMed Albright F, Henneman P, Benedict PH, Forbes AP (1953) Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 46:1077–1081PubMed
2.
Zurück zum Zitat Ammenti A, Neri E, Agistri R, Beseghi U, Bacchini E (2006) Idiopathic hypercalciuria in infants with renal stones. Pediatr Nephrol 21:1901–1903PubMedCrossRef Ammenti A, Neri E, Agistri R, Beseghi U, Bacchini E (2006) Idiopathic hypercalciuria in infants with renal stones. Pediatr Nephrol 21:1901–1903PubMedCrossRef
3.
Zurück zum Zitat Moore ES, Coe FL, McMann BJ, Favus MJ (1978) Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr 92:906–910PubMedCrossRef Moore ES, Coe FL, McMann BJ, Favus MJ (1978) Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr 92:906–910PubMedCrossRef
4.
Zurück zum Zitat Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR (2010) Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 42:471–475PubMedCrossRef Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR (2010) Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 42:471–475PubMedCrossRef
5.
Zurück zum Zitat Frick KK, Bushinsky DA (2003) Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14:1082–1095PubMedCrossRef Frick KK, Bushinsky DA (2003) Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14:1082–1095PubMedCrossRef
6.
7.
8.
Zurück zum Zitat Weisinger JR, Alonzo E, Carlini RG, Paz-Martinez V, Martinis R, Bellorin-Font E (1998) Bone disease in hypercalciuria: a new form of osteodystrophy? Nephrol Dial Transplant 13 [Suppl 3]:88–90PubMedCrossRef Weisinger JR, Alonzo E, Carlini RG, Paz-Martinez V, Martinis R, Bellorin-Font E (1998) Bone disease in hypercalciuria: a new form of osteodystrophy? Nephrol Dial Transplant 13 [Suppl 3]:88–90PubMedCrossRef
9.
Zurück zum Zitat Weisinger JR (1996) New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 49:1507–1518PubMedCrossRef Weisinger JR (1996) New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 49:1507–1518PubMedCrossRef
10.
Zurück zum Zitat Tasca A, Dalle Carbonare L, Nigro F, Giannini S (2009) Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis. Urology 74:22–27PubMedCrossRef Tasca A, Dalle Carbonare L, Nigro F, Giannini S (2009) Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis. Urology 74:22–27PubMedCrossRef
11.
Zurück zum Zitat Skalova S, Palicka V, Kutilek S (2005) Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria. Nephrology (Carlton) 10:99–102CrossRef Skalova S, Palicka V, Kutilek S (2005) Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria. Nephrology (Carlton) 10:99–102CrossRef
12.
Zurück zum Zitat Schwaderer AL, Cronin R, Mahan JD, Bates CM (2008) Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol 23:2209–2214PubMedCrossRef Schwaderer AL, Cronin R, Mahan JD, Bates CM (2008) Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol 23:2209–2214PubMedCrossRef
13.
Zurück zum Zitat Polito C, Iolascon G, Nappi B, Andreoli S, La Manna A (2003) Growth and bone mineral density in long-lasting idiopathic hypercalciuria. Pediatr Nephrol 18:545–547PubMed Polito C, Iolascon G, Nappi B, Andreoli S, La Manna A (2003) Growth and bone mineral density in long-lasting idiopathic hypercalciuria. Pediatr Nephrol 18:545–547PubMed
14.
Zurück zum Zitat Giannini S, Nobile M, Sella S, Dalle Carbonare L (2005) Bone disease in primary hypercalciuria. Crit Rev Clin Lab Sci 42:229–248PubMedCrossRef Giannini S, Nobile M, Sella S, Dalle Carbonare L (2005) Bone disease in primary hypercalciuria. Crit Rev Clin Lab Sci 42:229–248PubMedCrossRef
15.
Zurück zum Zitat Garcia-Nieto V, Ferrandez C, Monge M, de Sequera M, Rodrigo MD (1997) Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 11:578–583PubMedCrossRef Garcia-Nieto V, Ferrandez C, Monge M, de Sequera M, Rodrigo MD (1997) Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 11:578–583PubMedCrossRef
16.
Zurück zum Zitat Garcia-Nieto V, Navarro JF, Ferrandez C (1998) Bone loss in children with idiopathic hypercalciuria. Nephron 78:341–342PubMedCrossRef Garcia-Nieto V, Navarro JF, Ferrandez C (1998) Bone loss in children with idiopathic hypercalciuria. Nephron 78:341–342PubMedCrossRef
17.
Zurück zum Zitat Penido MG, Lima EM, Souto MF, Marino VS, Tupinamba AL, Franca A (2006) Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria? Pediatr Nephrol 21:74–78PubMedCrossRef Penido MG, Lima EM, Souto MF, Marino VS, Tupinamba AL, Franca A (2006) Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria? Pediatr Nephrol 21:74–78PubMedCrossRef
18.
Zurück zum Zitat Penido MG, Lima EM, Marino VS, Tupinamba AL, Franca A, Souto MF (2003) Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol 18:133–139PubMed Penido MG, Lima EM, Marino VS, Tupinamba AL, Franca A, Souto MF (2003) Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol 18:133–139PubMed
19.
Zurück zum Zitat Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989) Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 4:113–118PubMedCrossRef Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989) Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 4:113–118PubMedCrossRef
20.
Zurück zum Zitat Weisinger JR, Alonzo E, Bellorin-Font E, Blasini AM, Rodriguez MA, Paz-Martinez V, Martinis R (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250PubMedCrossRef Weisinger JR, Alonzo E, Bellorin-Font E, Blasini AM, Rodriguez MA, Paz-Martinez V, Martinis R (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250PubMedCrossRef
21.
Zurück zum Zitat Gowen M, Mundy GR (1986) Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J Immunol 136:2478–2482PubMed Gowen M, Mundy GR (1986) Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J Immunol 136:2478–2482PubMed
22.
Zurück zum Zitat Gomes SA, dos Reis LM, Noronha IL, Jorgetti V, Heilberg IP (2008) RANKL is a mediator of bone resorption in idiopathic hypercalciuria. Clin J Am Soc Nephrol 3:1446–1452PubMedCrossRef Gomes SA, dos Reis LM, Noronha IL, Jorgetti V, Heilberg IP (2008) RANKL is a mediator of bone resorption in idiopathic hypercalciuria. Clin J Am Soc Nephrol 3:1446–1452PubMedCrossRef
23.
Zurück zum Zitat Freundlich M, Alonzo E, Bellorin-Font E, Weisinger JR (2002) Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 17:1396–1401PubMedCrossRef Freundlich M, Alonzo E, Bellorin-Font E, Weisinger JR (2002) Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 17:1396–1401PubMedCrossRef
24.
Zurück zum Zitat Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V (2002) Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57:183–191PubMed Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V (2002) Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57:183–191PubMed
25.
Zurück zum Zitat Santos ACS Jr, Lima EM, Oliveira EA, Simões e Silva AC (2011) Bone disease and cytokines in idiopathic hypercalciuria: a review. J Pediatr Endocrinol Metab 24:405–410PubMedCrossRef Santos ACS Jr, Lima EM, Oliveira EA, Simões e Silva AC (2011) Bone disease and cytokines in idiopathic hypercalciuria: a review. J Pediatr Endocrinol Metab 24:405–410PubMedCrossRef
26.
Zurück zum Zitat Butani L, Kalia A (2004) Idiopathic hypercalciuria in children—how valid are the existing diagnostic criteria? Pediatr Nephrol 19:577–582PubMedCrossRef Butani L, Kalia A (2004) Idiopathic hypercalciuria in children—how valid are the existing diagnostic criteria? Pediatr Nephrol 19:577–582PubMedCrossRef
27.
28.
Zurück zum Zitat Hughes P (2007) The CARI guidelines. Kidney stones: metabolic evaluation. Nephrology (Carlton) 12 [Suppl 1]:31–33CrossRef Hughes P (2007) The CARI guidelines. Kidney stones: metabolic evaluation. Nephrology (Carlton) 12 [Suppl 1]:31–33CrossRef
29.
Zurück zum Zitat Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121PubMedCrossRef Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121PubMedCrossRef
30.
Zurück zum Zitat Brandao CM, Camargos BM, Zerbini CA, Plapler PG, Mendonca LM, Albergaria BH, Pinheiro MM, Prado M, Eis SR (2009) 2008 official positions of the Brazilian Society for Clinical Densitometry—SBDens. Arq Bras Endocrinol Metabol 53:107–112PubMedCrossRef Brandao CM, Camargos BM, Zerbini CA, Plapler PG, Mendonca LM, Albergaria BH, Pinheiro MM, Prado M, Eis SR (2009) 2008 official positions of the Brazilian Society for Clinical Densitometry—SBDens. Arq Bras Endocrinol Metabol 53:107–112PubMedCrossRef
31.
Zurück zum Zitat Baroncelli GI, Bertelloni S, Sodini F, Saggese G (2005) Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs 7:295–323PubMedCrossRef Baroncelli GI, Bertelloni S, Sodini F, Saggese G (2005) Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs 7:295–323PubMedCrossRef
32.
Zurück zum Zitat Souto MF, Teixeira AL, Russo RC, Penido MG, Silveira KD, Teixeira MM, Simoes e Silva AC (2008) Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria. Pediatr Res 64:637–642PubMedCrossRef Souto MF, Teixeira AL, Russo RC, Penido MG, Silveira KD, Teixeira MM, Simoes e Silva AC (2008) Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria. Pediatr Res 64:637–642PubMedCrossRef
33.
Zurück zum Zitat Volejnikova S, Laskari M, Marks SC Jr, Graves DT (1997) Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse. Am J Pathol 150:1711–1721PubMed Volejnikova S, Laskari M, Marks SC Jr, Graves DT (1997) Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse. Am J Pathol 150:1711–1721PubMed
34.
Zurück zum Zitat Yadav A, Saini V, Arora S (2010) MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 411:1570–1579PubMedCrossRef Yadav A, Saini V, Arora S (2010) MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 411:1570–1579PubMedCrossRef
35.
Zurück zum Zitat Posner LJ, Miligkos T, Gilles JA, Carnes DL, Taddeo DR, Graves DT (1997) Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. Bone 21:321–327PubMedCrossRef Posner LJ, Miligkos T, Gilles JA, Carnes DL, Taddeo DR, Graves DT (1997) Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. Bone 21:321–327PubMedCrossRef
36.
Zurück zum Zitat Lorenzo J, Horowitz M, Choi Y (2008) Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29:403–440PubMedCrossRef Lorenzo J, Horowitz M, Choi Y (2008) Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29:403–440PubMedCrossRef
37.
Zurück zum Zitat Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16:1787–1794PubMedCrossRef Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16:1787–1794PubMedCrossRef
39.
Zurück zum Zitat Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K (1990) Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71:138–145PubMedCrossRef Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K (1990) Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71:138–145PubMedCrossRef
40.
Zurück zum Zitat Giannini S, Nobile M, Sartori L, Dalle Carbonare L, Ciuffreda M, Corrò P, D’Angelo A, Calò L, Crepaldi G (1999) Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 69:267–271PubMed Giannini S, Nobile M, Sartori L, Dalle Carbonare L, Ciuffreda M, Corrò P, D’Angelo A, Calò L, Crepaldi G (1999) Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 69:267–271PubMed
41.
Zurück zum Zitat Shroff R, Knott C, Rees L (2010) The virtues of vitamin D—but how much is too much? Pediatr Nephrol 25:1607–1620PubMedCrossRef Shroff R, Knott C, Rees L (2010) The virtues of vitamin D—but how much is too much? Pediatr Nephrol 25:1607–1620PubMedCrossRef
42.
Zurück zum Zitat Soylemezoglu O, Ozkaya O, Gonen S, Misirlioglu M, Kalman S, Buyan N (2004) Vitamin D receptor gene polymorphism in hypercalciuric children. Pediatr Nephrol 19:724–727PubMedCrossRef Soylemezoglu O, Ozkaya O, Gonen S, Misirlioglu M, Kalman S, Buyan N (2004) Vitamin D receptor gene polymorphism in hypercalciuric children. Pediatr Nephrol 19:724–727PubMedCrossRef
43.
Zurück zum Zitat Borges JL, Brandao CM (2006) Low bone mass in children and adolescents. Arq Bras Endocrinol Metabol 50:775–782PubMedCrossRef Borges JL, Brandao CM (2006) Low bone mass in children and adolescents. Arq Bras Endocrinol Metabol 50:775–782PubMedCrossRef
44.
Zurück zum Zitat Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A (1997) Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82:32–38PubMedCrossRef Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A (1997) Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82:32–38PubMedCrossRef
Metadaten
Titel
Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria
verfasst von
Augusto C. S. Santos Jr
Eleonora M. Lima
Maria Goretti M. G. Penido
Katia D. Silveira
Mauro M. Teixeira
Eduardo A. Oliveira
Ana Cristina Simões e Silva
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 6/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-2094-4

Weitere Artikel der Ausgabe 6/2012

Pediatric Nephrology 6/2012 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.